drug-repositioning

Drug Positioning and Repositioning

We profile compounds, whether in late development, in the market or at the generic phase and match them with diseases to find new uses for drugs or new therapies for indications of interest. more…

Personalized Medicine

Given the holistic context of N=1 patient, what drug regimen makes most sense, from both a benefit and risk perspective?

In-Stream Trial Analytics and De-risking

We correlate trial data in real time and look for signal/noise that may derail a trial. We also run this in reverse, to help identify the right subpopulations. more…

New Target Biology

We parse diseases and identify unanticipated mechanisms for new generation druggable targets. We then combine with repositioning. more…

Real-world AI in healthcare, and beyond

Healthcare stakeholders

Biopharma Companies

Biovista B2B Services offer a proven and cost effective management tool to exploit or salvage a specific compound, develop a new therapy for a medical need or manage your pipeline … more

Generics Companies

Looking to move beyond branded and super generics? Partner with Biovista to create value and differentiation through drug repositioning, combination therapies, novel delivery routes and formulations … more

Patient Advocacy Groups

The reality of rare and neglected diseases makes drug repositioning a highly relevant strategy for therapy development. We partner with patient groups to advance therapies using novel, cost effective collaboration models … more

Reagent and Life-sciences product companies

How do you support researchers and make the buying of reagents and life sciences products a more engaging and useful experience? Biovista’s Vizit platform shows the way … more

Perhaps one of the most innovative companies of #AI in #healthcare. Very proud to have collaborated.

— Spiros Liolis AI, Blockchain and Digital Transformation Business Development Manager & CTO, Hewlett Packard Enterprise

Hard to believe it’s been 10 years changing the world of healthcare. I am so grateful to be working with you and the team at Biovista. Keep on track, change the world. #ThankYou

— Cliff Farah President, The Beacon Group

Exciting technology for providing quantum leaps in healthcare-related analytics. The Oral Roberts University data analytics research team is thrilled to engage with Biovista in exploring the ramifications of Project Prodigy.

— Stephen Wheat Professor of Computer Science and Director of HPC, Oral Roberts University
CONTACT US!

Get in touch

    First Name*

    Last Name*

    E-mail*

    Organization*

    Message for us

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.